|
WO2017147427A1
|
|
System and method for microscopic observation of microbial fitness
|
|
WO2016123575A1
|
|
Compositions and methods for modulating eph receptor binding and signaling
|
|
US2017056422A1
|
|
Plasmodium liver-stage inhibitors and related methods
|
|
WO2012159075A1
|
|
Bioprobe compositions and their methods of use
|
|
WO2008147826A1
|
|
Malaria liver stage drugs
|
|
US2008213291A1
|
|
Malaria vaccines
|
|
US2008267993A1
|
|
AIDS vaccines
|
|
EP1937715A2
|
|
Plasmodium liver stage antigens
|
|
CN101321778A
|
|
Plasmodium liver stage antigens
|
|
US2008248063A1
|
|
Hetero-Oligomeric Hiv Envelope Proteins
|
|
US2006121060A1
|
|
Live genetically engineered protozoan vaccine
|
|
OA13341A
|
|
Live genetically attenuated malaria vaccine.
|
|
CA2391657A1
|
|
Anti-transforming growth factor beta (tgf-.beta.) treated stem cell composition and method
|
